MACKENZIE YOUNG: Open Payments
NPI 1437619301 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 41 payments from 8 companies in 2025. Trend: 2023 $2,126 · 2024 $924 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $222 |
| Celgene Corporation | 10 | $136 |
| Novartis Pharmaceuticals Corporation | 6 | $111 |
| PFIZER INC. | 6 | $111 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| ARRAY BIOPHARMA INC | 2 | $29 |
| Janssen Biotech, Inc. | 1 | $15 |
| Exelixis Inc. | 1 | $15 |
Products named: REBLOZYL, EPKINLY, IMBRUVICA, PADCEV, KISQALI, VENCLEXTA, XTANDI, LUTATHERA.
Industry payments across NY — which companies pay providers there.
